These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6502175)

  • 21. Visuospatial working memory in Parkinson's disease.
    Bradley VA; Welch JL; Dick DJ
    J Neurol Neurosurg Psychiatry; 1989 Nov; 52(11):1228-35. PubMed ID: 2592967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual and auditory evoked responses in patients with Parkinson's disease.
    Gawel MJ; Das P; Vincent S; Rose FC
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):227-32. PubMed ID: 7229646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Everyday memory impairment in Parkinson's disease].
    Katai S
    Rinsho Shinkeigaku; 1999 Sep; 39(9):913-9. PubMed ID: 10614153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson's disease.
    Rolinski M; Zokaei N; Baig F; Giehl K; Quinnell T; Zaiwalla Z; Mackay CE; Husain M; Hu MT
    Brain; 2016 Jan; 139(Pt 1):47-53. PubMed ID: 26582557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic deficiency and frontal dysfunction in Parkinson's disease.
    Dubois B; Pilon B; Lhermitte F; Agid Y
    Ann Neurol; 1990 Aug; 28(2):117-21. PubMed ID: 2221841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy.
    Marini P; Ramat S; Ginestroni A; Paganini M
    Neurol Sci; 2003 Oct; 24(3):184-5. PubMed ID: 14598078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthalamic nucleus stimulation selectively improves motor and visual memory performance in Parkinson's disease.
    Mollion H; Dominey PF; Broussolle E; Ventre-Dominey J
    Mov Disord; 2011 Sep; 26(11):2019-25. PubMed ID: 21611980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Psychological changes in patients with Parkinson's disease during treatment with L-Dopa. Interpretation and comprehension of the observed phenomena].
    Fau R; Perret J; Israël L; Ohlmann T
    Ann Med Psychol (Paris); 1975 May; 1(5):670-83. PubMed ID: 1233896
    [No Abstract]   [Full Text] [Related]  

  • 31. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical therapy of Parkinson's disease.
    Kurlan R
    Semin Neurol; 1987 Jun; 7(2):160-6. PubMed ID: 3332453
    [No Abstract]   [Full Text] [Related]  

  • 33. Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.
    Merello M; Lees AJ
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1024-6. PubMed ID: 1469397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-lasting drug holiday in Parkinson's disease.
    Bermejo F; Calandre L; Molina JA; Martinez P; De Yebenes JG
    Adv Neurol; 1987; 45():503-6. PubMed ID: 3103392
    [No Abstract]   [Full Text] [Related]  

  • 35. Level of blood pressure in patients with Parkinson's disease. A case-control study.
    Marttila RJ; Rinne UK
    Eur Neurol; 1977; 16(1-6):73-8. PubMed ID: 354939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The phonological loop in medicated patients with Parkinson's disease: presence of phonological similarity and word length effects.
    Moreaud O; Fournet N; Roulin JL; Naegele B; Pellat J
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):609-11. PubMed ID: 9219747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine and memory function in Parkinson's disease.
    Mohr E; Fabbrini G; Williams J; Schlegel J; Cox C; Fedio P; Chase TN
    Mov Disord; 1989; 4(2):113-20. PubMed ID: 2543918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical therapeutics: advances in the management of Parkinson's disease.
    Adam AM
    East Afr Med J; 1985 Feb; 62(2):143-6. PubMed ID: 3930202
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of anticholinergic drugs on memory in Parkinson's disease.
    Sadeh M; Braham J; Modan M
    Arch Neurol; 1982 Oct; 39(10):666-7. PubMed ID: 7125982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.